544222 logo

Akums Drugs and Pharmaceuticals BSE:544222 Stock Report

Last Price

₹803.70

Market Cap

₹125.9b

7D

n/a

1Y

n/a

Updated

09 Aug, 2024

Data

Company Financials

Akums Drugs and Pharmaceuticals Limited

BSE:544222 Stock Report

Market Cap: ₹125.9b

544222 Stock Overview

Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally.

544222 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Akums Drugs and Pharmaceuticals Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Akums Drugs and Pharmaceuticals
Historical stock prices
Current Share Price₹803.70
52 Week High₹822.40
52 Week Low₹724.50
Beta0
11 Month Changen/a
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO0.92%

Recent News & Updates

Recent updates

Shareholder Returns

544222IN PharmaceuticalsIN Market
7Dn/a1.8%-3.5%
1Yn/a47.8%41.1%

Return vs Industry: Insufficient data to determine how 544222 performed against the Indian Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how 544222 performed against the Indian Market.

Price Volatility

Is 544222's price volatile compared to industry and market?
544222 volatility
544222 Average Weekly Movementn/a
Pharmaceuticals Industry Average Movement6.0%
Market Average Movement6.6%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market4.3%

Stable Share Price: 544222 has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 544222's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20047,388Sanjeev Jainwww.akums.in

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company.

Akums Drugs and Pharmaceuticals Limited Fundamentals Summary

How do Akums Drugs and Pharmaceuticals's earnings and revenue compare to its market cap?
544222 fundamental statistics
Market cap₹125.87b
Earnings (TTM)-₹40.35m
Revenue (TTM)₹41.82b

3.0x

P/S Ratio

-3,132x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
544222 income statement (TTM)
Revenue₹41.82b
Cost of Revenue₹26.20b
Gross Profit₹15.61b
Other Expenses₹15.65b
Earnings-₹40.35m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-0.26
Gross Margin37.34%
Net Profit Margin-0.097%
Debt/Equity Ratio68.2%

How did 544222 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.